Litcius/Paper detail

MicroRNA dysregulations in Merkel cell carcinoma: Molecular mechanisms and clinical applications

Chiara Mazziotta, Christian Felice Cervellera, Carmen Lanzillotti, Antoine Touzé, Pauline Gaboriaud, Mauro Tognon, Fernanda Martini, John Charles Rotondo

2022Journal of Medical Virology43 citationsDOI

Abstract

Merkel cell carcinoma (MCC) is an aggressive skin malignancy with two distinct etiologies. The first, which accounts for the highest proportion, is caused by Merkel cell polyomavirus (MCPyV), a DNA tumor virus. A second, UV-induced, MCC form has also been identified. Few MCC diagnostic, prognostic, and therapeutic options are available. MicroRNAs (miRNAs) are small noncoding RNA molecules, which play a key role in regulating various physiologic cellular functions including cell cycling, proliferation, differentiation, and apoptosis. Numerous miRNAs are dysregulated in cancer, by acting as either tumor suppressors or oncomiRs. The aim of this review is to collect, summarize, and discuss recent findings on miRNAs whose dysregulation has been assumed to play a role in MCC. The potential clinical application of miRNAs as diagnostic and prognostic biomarkers in MCC is also described. In the future, miRNAs will potentially gain clinical significance for the improvement of MCC diagnostic, prognostic, and therapeutic options.

Topics & Concepts

Merkel cell carcinomamicroRNAMerkel cell polyomavirusMalignancyCancer researchBiologyCancerSuppressorBioinformaticsCarcinomaGeneGeneticsPolyomavirus and related diseasesFull-Duplex Wireless CommunicationsAntenna Design and Analysis
MicroRNA dysregulations in Merkel cell carcinoma: Molecular mechanisms and clinical applications | Litcius